Yiwen Chen
Affiliations: | Bioinformatics & Comp Biology | The University of Texas MD Anderson Cancer Center |
Google:
"Yiwen Chen"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zheng C, Wei Y, Zhang P, et al. (2023) CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames. Nature Structural & Molecular Biology |
Zhang L, He W, Fu R, et al. (2023) Guide-specific loss of efficiency and off-target reduction with Cas9 variants. Nucleic Acids Research |
Zheng C, Wei Y, Zhang Q, et al. (2023) Multiomics analyses reveal /YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance. Science Advances. 9: eadf3984 |
Zheng C, Wei Y, Zhang P, et al. (2023) CRISPR/Cas9 screen uncovers functional translation of cryptic lncRNA-encoded open reading frames in human cancer. The Journal of Clinical Investigation. 133 |
Fu R, He W, Dou J, et al. (2022) Systematic decomposition of sequence determinants governing CRISPR/Cas9 specificity. Nature Communications. 13: 474 |
Sun M, Wang Y, Zheng C, et al. (2021) Systematic functional interrogation of human pseudogenes using CRISPRi. Genome Biology. 22: 240 |
He W, Wang H, Wei Y, et al. (2021) GuidePro: A multi-source ensemble predictor for prioritizing sgRNAs in CRISPR/Cas9 protein knockouts. Bioinformatics (Oxford, England) |
Zi Z, Zhang Y, Zhang P, et al. (2019) A Proteomic Connectivity Map for Characterizing the Tumor Adaptive Response to Small Molecule Chemical Perturbagens. Acs Chemical Biology |
Nguyen TM, Kabotyanski EB, Dou Y, et al. (2018) FGFR1-activated Translation of WNT Pathway Components with Structured 5' UTRs is Vulnerable to Inhibition of EIF4A-dependent Translation Initiation. Cancer Research |
Zhao N, Cao J, Xu L, et al. (2018) Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. The Journal of Clinical Investigation |